Transcriptional up-regulation of paxillin expression by heregulin in human breast cancer cells

Cancer Research

Volumn 59, Issue 12, 1999, Pages 2843-2846

  Vadlamudi, Ratna ^a   Adam, Liana ^a   Tseng, Ben ^a   Costa, Louis ^b   Kumar, Rakesh ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXIMIDE; DACTINOMYCIN; GAMMA UROGASTRONE; NEU DIFFERENTIATION FACTOR; PAXILLIN;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CELL MIGRATION; CELL MOTILITY; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

BREAST NEOPLASMS; CARRIER PROTEINS; CYTOSKELETAL PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEUREGULIN-1; PAXILLIN; PHOSPHOPROTEINS; RECEPTOR, ERBB-2; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0033564110     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., and Ullrich, A. Science (Washington DC), 244: 707-712, 1989.
2. Reese D. M., and Slamon, D. J. Her2/neu signal transduction in human breast and ovarian cancer. Stem Cells, 15: 1-8, 1997.
3. Plowman, G. D., Green, J. M., Culouscou, J. M., Carlton, G. W., Rothwell, V. M., and Buckley, S. Heregulin induces tyrosine phosphorylation of HER4/p180erbB4. Nature (Lond.), 366: 473-475, 1993.
4. Hynes, N. C., and Stem, D. F. The biology of erbB2/neu/HER2 and its role in cancer. Biochim. Biophys. Acta, 1198: 165-184, 1994.
5. Peles, E., Bacus, S. S., Koski, R. A., Lu, H. S., Wen, D., Ogden, S. G., Levy, R. B., and Yarden, Y. Isolation of the Neu/HER2 stimulatory ligand: a 44 kD protein in estrogen receptor positive breast cancer cell lines. Cell, 69: 205-216, 1992.
6. Tang, C. K., Perez, C., Grunt, T., Waibel, C., Cho, C., and Lupu, R. Involvement of heregulin β2 in the acquisition of the hormone-independent phenotype of breast cancer cells. Cancer Res., 56: 3350-3358, 1996.
7. Kumar, R., Mandal, M., Ratzkin, B. J., Liu, N., and Lipton, A. NDF induces expression of a novel 46 kd protein in estrogen receptor positive breast cancer cells. J. Cell. Biochem., 62: 102-112, 1995.
8. Mitchison, T. J., and Cramer, L. P. Actin based cell motility and cell locomotion. Cell, 84: 371-379, 1996.
9. Burridge, K., Chrzanowska-Wodnicka, M., and Zhong, C. Focal adhesion assembly. Trends Cell Biol., 7: 342-347, 1997.
10. Bergman, M., Joukov, V., Virtanen, I., and Alitalo, K. Overexpressed Crk tyrosine kinase is localized in focal adhesions, causes reorganization of αvβ integrin, and interferes with Hela cell spreading. Mol. Cell. Biol., 15: 711-722, 1995.
11. Schlaepfer, D. D., Hanks, S. K., Hunter, T., and Geer, V. D. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature (Lond.), 372: 786-791, 1994.
12. Bellis, S. L., Miller, J. T., and Turner, C. E. Characterization of tyrosine phosphorylation of paxillin in vitro by focal adhesion kinase. J. Biol. Chem., 270; 17437-17441, 1995.
13. Abedi, H., Dawes, K. E., and Zachary, I. Differential effects of the platelet derived growth factor BB on p 125 focal adhesion kinase and paxillin tyrosine phosphorylation and on cell migration in rabbit aortic vascular smooth muscle cells and Swiss 3T3 fibroblasts. J. Biol. Chem., 270: 11367-11376, 1995.
14. Abedi, H., and Zachary, I. Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells. J. Biol. Chem., 272: 15442-15451, 1997.
15. Leventhal, P. S., Shelden, E. A., Kim, B., and Feldman, E. L. Tyrosine phosphorylation of paxillin and focal adhesion kinase during insulin-like growth factor-stimulated lamellipodial advance. J. Biol. Chem., 272: 5214-5218, 1997.
16. Matsumoto, K., Matsumoto, K., Nakamura, T., and Kramer, R. H. Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (p125FAK) and promotes migration and invasion by oral squamous cell carcinoma cells. J. Biol. Chem., 269: 31807-31813, 1994.
17. Hiregowdara, D., Avraham, H., Fu, Y., London, R., and Avraham, S. Tyrosine phosphorylation of the related adhesion focal tyrosine kinase in megakaryocytes upon stem cell factor and phorbol myristate acetate stimulation and its association with paxillin. J. Biol. Chem., 272: 10804-10810, 1997.
18. Yang, Y., Spitzer, E., Meyer, D., Sach, M., Niemann, C., Hartmann, G., Weidner, K. M., Birchmeier, C., and Birchmeier, W. Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of mammary gland. J. Cell. Biol., 131: 215-226, 1995.
19. Jones, F. E., Jerry, D. J., Guarino, B. C., Andrews, G. C., and Stem, D. F. Heregulin induces in vivo proliferation and differentiation of mammary epithelium into secretory lobuloalveoli. Cell Growth Differ., 7: 1031-1038, 1996.
20. Krane, I. M., and Leder, P. NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice. Oncogene, 12: 1781-1788, 1996.
21. Adam, L., Vadlamudi, R., Kondapaka, S., Chernoff, J., Mendelsohn, J., and Kumar, R. Heregulin regulates cytoskeletal reorganization and cell migration through the p21 activated kinase-1 via phosphotidylinositol-3 kinase. J. Biol. Chem., 273: 28238-28246, 1998.
22. Lewis, G. D., Lofgren, J. A., McMurtrey, A. E., Nuijens, A., Fendly, B. M., Bauer, K. D., and Sliwkowski, M. X. Growth regulation of human breast and ovarian tumor cells by heregulin: evidence for the requirement of erbB2 as a critical component in mediating heregulin responsiveness. Cancer Res., 56: 1457-1465, 1996.
23. Salgia, R., Li, J. L., Lo, S. H., Brunkhorst, B., Kansas, G. S., Sobhany, E. S., Sun, Y., Pisick, E., Hallek, M., Tantravahi, R., Chen, L. B., and Griffin, J. D. Molecular cloning of human paxillin, a focal adhesion protein phosphorylated by p210BCR/ ABL. J. Biol. Chem., 270: 5039-5047, 1995.
24. Meijne, A. M., Ruuls-Van, S. L., Feltkamp, C. A., McCarthy, J. B., and Roos, E. V-src induced cell shape changes in RAT fibroblasts require new gene transcription and precede loss of focal adhesions. Exp. Cell Res., 234: 447-485, 1997.
25. Turner, C. E. Molecule in focus: paxillin. Int. J. Biochem. Cell Biol., 30: 955-959, 1998.
26. Tremblay, L., Hauck, W., Aprikian, A. G., Begin, L. G., Chapdelaine, A., and Chevalier, S. Focal adhesion kinase expression, activation and association and p50csk in human metastatic prostate carcinoma. Int. J. Cancer, 68: 164-171, 1996.
27. Koukouritaki, S. B., Tamizuddin, A., and Lianos, E. A. Enhanced expression of the cytoskeletal-associated protein paxillin in experimental nephrotic syndrome. J. Invest. Med., 46: 284-289, 1998.
28. Lo, L., Lo, S. H., Wang, S., and Hung, M. Focal contact formation is inhibited in NIH3T3 cells transformed by p185neu. Mol. Carcinogenesis, in press, 1999.